Global plasma fractionation market is anticipated to grow at a formidable growth rate during the forecast period owing to its wide usage in prevention and treatment of life-threatening diseases caused by trauma, immunologic disorders, and chronic infections. Additionally, increasing use of immunoglobulins in diagnosis and treatment of the metabolic disorders is acting as a key factor behind the growth of global plasma fractionation market. Also, increasing geriatric population across the globe and rising prevalence of respiratory diseases including the recent outbreak of coronavirus is leading to significant demand for plasma fractionation.

Plasma fractionation is basically processing wherein various components of plasma are separated through blood fractionation and then Fresh Frozen Plasma (FFP) can be used for replacement of clotting factors. Plasma contains an innumerable variety of proteins. Around 20 of these proteins serve to produce plasma products, which are used to cure severe plasma conditions.

Global plasma fractionation market can be segmented based on product, method, plasma source, test, donor, application, end-user and region. Based on product, the market is segmented into coagulation factors, immunoglobins, protease inhibitor, anticoagulants and albumin. The coagulation factors segment is further divided into factor VIII, factor IX, prothrombin, fibrinogen and others. Further, the protease inhibitor segment is divided into Alpha-1-Antitrypsin and C1-inhibitor. The immunoglobins segment dominates the global market owing to the diversified use of immunoglobulin in various disorders such as primary and secondary immune deficiencies, autoimmune diseases, and inflammatory diseases.

Major companies operating in the plasma fractionation market include Grifols, Baxter, CSL Behring, Bio Products Laboratory, Biotest AG, China Biologic Products, Benesis Corporation, Kedrion S.p.A, Octapharma, Shire, LFB, Sanquin, GC Pharma (Green Cross Corporation), Takeda Pharmaceutical, Hualan Bio, Eli Lily, Roche, Bayer, Becton Dickinson, Intas Pharmaceutical, among others. The companies are indulging in acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures to make a strong foothold in the global plasma fractionation market.

Objective of the Study:

  • To analyze and forecast the market size of global plasma fractionation market.
  • To forecast global plasma fractionation market based on product, method, plasma source, test, donor, application, end-user and regional distribution.
  • To identify drivers and challenges for global plasma fractionation market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global plasma fractionation market.
  • To identify and analyze the profile of leading players operating in the global plasma fractionation market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of plasma fractionation companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the suppliers which could not be identified due to the limitations of secondary research.

TechSci Research calculated global plasma fractionation market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.

Key Target Audience:

  • Plasma fractionation companies, service providers and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to plasma fractionation
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as plasma fractionation companies, partners, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Attribute

Details

Base Year

2021

Historical Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, Volume in Units and CAGR for 2017-2021 and 2022E-2027F

Report coverage

Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends

Segments covered
  • Product
  • Method
  • Plasma Source
  • Test
  • Donor
  • Application
  • End User

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States, Mexico, Canada, China, India, Japan, South Korea, Australia; Singapore; Germany, France, United Kingdom, Russia, Italy; South Africa, UAE, Saudi Arabia; Brazil, Argentina, Colombia;

Key companies profiled

Grifols, Baxter, CSL Behring, Bio Products Laboratory, Biotest AG, China Biologic Products, Benesis Corporation, Kedrion S.p.A, Octapharma, Shire, LFB, Sanquin, GC Pharma (Green Cross Corporation), Takeda Pharmaceutical, Hualan Bio, Eli Lily, Roche, Bayer, Becton Dickinson, Intas Pharmaceutical.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global plasma fractionation market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Plasma Fractionation Market, By Product:
    • Coagulation Factors
      • Factor VIII
      • Factor IX
      • Prothrombin
      • Fibrinogen
      • Others
    • Immunoglobins
    • Protease Inhibitor
      • Alpha-1-Antitrypsin
      • C1-inhibitor
    • Anticoagulants
    • Albumin
  • Global Plasma Fractionation Market, By Method:
    • Cohn Cold Fractioning Process
    • Chromatography
    • Cryoprecipitation
    • Molecular Imprinting
    • Salt Diafiltration Process
    • Others
  • Global Plasma Fractionation Market, By Plasma Source:
    • Blood Test
    • Plasmapheresis
  • Global Plasma Fractionation Market, By Test:
    • NAT-testing
    • ELISA
    • Screening Test
  • Global Plasma Fractionation Market, By Donor:
    • Recovered Plasma
    • Source Plasma
  • Global Plasma Fractionation Market, By Application:
    • Neurology
    • Immunology
    • Hematology
    • Others
  • Global Plasma Fractionation Market, By End-User:
    • Hospitals and Clinics
    • Clinical Research Laboratories
    • Others
  • Global Plasma Fractionation Market, By Region:
    • Asia-Pacific
      • China
      • Japan
      • India 
      • South Korea
      • Singapore
      • Australia
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Russia
    • North America
      • United States
      • Mexico
      • Canada
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • UAE
      • South Africa
      • Saudi Arabia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global plasma fractionation market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

  • Profit margin analysis in case of direct and indirect sales channel.

It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Plasma Fractionation Market

4.    Executive Summary

5.    Global Plasma Fractionation Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value & Volume

5.2.  Market Share & Forecast

5.2.1.     By Product

5.2.1.1.1.             Coagulation Factors (Factor VIII, Factor IX, Prothrombin, Fibrinogen, Others)

5.2.1.1.2.             Immunoglobins (IgGs)

5.2.1.1.3.             Protease Inhibitor (Alpha-1-Antitrypsin, C1-inhibitor)

5.2.1.1.4.             Anticoagulants(antithrombin)

5.2.1.1.5.             Albumin

5.2.2.     By Method (Cohn Cold Fractioning Process, Chromatography, Cryoprecipitation, Molecular Imprinting, Salt Diafiltration Process, Others)

5.2.3.     By Plasma Source (Blood Test, Plasmapheresis)

5.2.4.     By Test (NAT-testing, ELISA, Screening Test)

5.2.5.     By Donor (Recovered Plasma, Source Plasma)

5.2.6.     By Application (Neurology, Immunology, Hematology, Others)

5.2.7.     By End-User (Hospitals and Clinics, Clinical Research Laboratories, Others)

5.2.8.     By Company (2021)

5.2.9.     By Region

5.3.  Market Attractiveness Index

6.    Asia-Pacific Plasma Fractionation Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value & Volume

6.2.  Market Share & Forecast

6.2.1.     By Product

6.2.2.     By Method

6.2.3.     By Plasma Source

6.2.4.     By Test

6.2.5.     By Donor

6.2.6.     By Application

6.2.7.     By End-User

6.2.8.     By Country

6.3.  Market Attractiveness Index

6.4.  Asia-Pacific: Country Analysis

6.4.1.     China Plasma Fractionation Market Outlook

6.4.1.1.         Market Size & Forecast

6.4.1.1.1.             By Value

6.4.1.2.         Market Share & Forecast

6.4.1.2.1.             By Product

6.4.1.2.2.             By Method

6.4.1.2.3.             By Plasma Source

6.4.1.2.4.             By Test

6.4.1.2.5.             By Donor

6.4.1.2.6.             By Application

6.4.1.2.7.             By End-User

6.4.2.     India Plasma Fractionation Market Outlook

6.4.2.1.         Market Size & Forecast

6.4.2.1.1.             By Value

6.4.2.2.         Market Share & Forecast

6.4.2.2.1.             By Product

6.4.2.2.2.             By Method

6.4.2.2.3.             By Plasma Source

6.4.2.2.4.             By Test

6.4.2.2.5.             By Donor

6.4.2.2.6.             By Application

6.4.2.2.7.             By End-User

6.4.3.     Japan Plasma Fractionation Market Outlook

6.4.3.1.         Market Size & Forecast

6.4.3.1.1.             By Value

6.4.3.2.         Market Share & Forecast

6.4.3.2.1.             By Product

6.4.3.2.2.             By Method

6.4.3.2.3.             By Plasma Source

6.4.3.2.4.             By Test

6.4.3.2.5.             By Donor

6.4.3.2.6.             By Application

6.4.3.2.7.             By End-User

6.4.4.     South Korea Plasma Fractionation Market Outlook

6.4.4.1.         Market Size & Forecast

6.4.4.1.1.             By Value

6.4.4.2.         Market Share & Forecast

6.4.4.2.1.             By Product

6.4.4.2.2.             By Method

6.4.4.2.3.             By Plasma Source

6.4.4.2.4.             By Test

6.4.4.2.5.             By Donor

6.4.4.2.6.             By Application

6.4.4.2.7.             By End-User

6.4.5.     Singapore Plasma Fractionation Market Outlook

6.4.5.1.         Market Size & Forecast

6.4.5.1.1.             By Value

6.4.5.2.         Market Share & Forecast

6.4.5.2.1.             By Product

6.4.5.2.2.             By Method

6.4.5.2.3.             By Plasma Source

6.4.5.2.4.             By Test

6.4.5.2.5.             By Donor

6.4.5.2.6.             By Application

6.4.5.2.7.             By End-User

6.4.6.     Australia Plasma Fractionation Market Outlook

6.4.6.1.         Market Size & Forecast

6.4.6.1.1.             By Value

6.4.6.2.         Market Share & Forecast

6.4.6.2.1.             By Product

6.4.6.2.2.             By Method

6.4.6.2.3.             By Plasma Source

6.4.6.2.4.             By Test

6.4.6.2.5.             By Donor

6.4.6.2.6.             By Application

6.4.6.2.7.             By End-User

7.    Europe Plasma Fractionation Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Product

7.2.2.     By Method

7.2.3.     By Plasma Source

7.2.4.     By Test

7.2.5.     By Donor

7.2.6.     By Application

7.2.7.     By End-User

7.2.8.     By Country

7.3.  Market Attractiveness Index

7.4.  Europe: Country Analysis

7.4.1.     France Plasma Fractionation Market Outlook

7.4.1.1.         Market Size & Forecast

7.4.1.1.1.             By Value

7.4.1.2.         Market Share & Forecast

7.4.1.2.1.             By Product

7.4.1.2.2.             By Method

7.4.1.2.3.             By Plasma Source

7.4.1.2.4.             By Test

7.4.1.2.5.             By Donor

7.4.1.2.6.             By Application

7.4.1.2.7.             By End-User

7.4.2.     Germany Plasma Fractionation Market Outlook

7.4.2.1.         Market Size & Forecast

7.4.2.1.1.             By Value

7.4.2.2.         Market Share & Forecast

7.4.2.2.1.             By Product

7.4.2.2.2.             By Method

7.4.2.2.3.             By Plasma Source

7.4.2.2.4.             By Test

7.4.2.2.5.             By Donor

7.4.2.2.6.             By Application

7.4.2.2.7.             By End-User

7.4.3.     United Kingdom Plasma Fractionation Market Outlook

7.4.3.1.         Market Size & Forecast

7.4.3.1.1.             By Value

7.4.3.2.         Market Share & Forecast

7.4.3.2.1.             By Product

7.4.3.2.2.             By Method

7.4.3.2.3.             By Plasma Source

7.4.3.2.4.             By Test

7.4.3.2.5.             By Donor

7.4.3.2.6.             By Application

7.4.3.2.7.             By End-User

7.4.4.     Italy Plasma Fractionation Market Outlook

7.4.4.1.         Market Size & Forecast

7.4.4.1.1.             By Value

7.4.4.2.         Market Share & Forecast

7.4.4.2.1.             By Product

7.4.4.2.2.             By Method

7.4.4.2.3.             By Plasma Source

7.4.4.2.4.             By Test

7.4.4.2.5.             By Donor

7.4.4.2.6.             By Application

7.4.4.2.7.             By End-User

8.    North America Plasma Fractionation Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value & Volume

8.2.  Market Share & Forecast

8.2.1.     By Product

8.2.2.     By Method

8.2.3.     By Plasma Source

8.2.4.     By Test

8.2.5.     By Donor

8.2.6.     By Application

8.2.7.     By End-User

8.2.8.     By Country

8.3.  Market Attractiveness Index

8.4.  North America: Country Analysis

8.4.1.     United States Plasma Fractionation Market Outlook

8.4.1.1.         Market Size & Forecast

8.4.1.1.1.             By Value

8.4.1.2.         Market Share & Forecast

8.4.1.2.1.             By Product

8.4.1.2.2.             By Method

8.4.1.2.3.             By Plasma Source

8.4.1.2.4.             By Test

8.4.1.2.5.             By Donor

8.4.1.2.6.             By Application

8.4.1.2.7.             By End-User

8.4.2.     Mexico Plasma Fractionation Market Outlook

8.4.2.1.         Market Size & Forecast

8.4.2.1.1.             By Value

8.4.2.2.         Market Share & Forecast

8.4.2.2.1.             By Product

8.4.2.2.2.             By Method

8.4.2.2.3.             By Plasma Source

8.4.2.2.4.             By Test

8.4.2.2.5.             By Donor

8.4.2.2.6.             By Application

8.4.2.2.7.             By End-User

8.4.3.     Canada Plasma Fractionation Market Outlook

8.4.3.1.         Market Size & Forecast

8.4.3.1.1.             By Value

8.4.3.2.         Market Share & Forecast

8.4.3.2.1.             By Product

8.4.3.2.2.             By Method

8.4.3.2.3.             By Plasma Source

8.4.3.2.4.             By Test

8.4.3.2.5.             By Donor

8.4.3.2.6.             By Application

8.4.3.2.7.             By End-User

9.    South America Plasma Fractionation Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value & Volume

9.2.  Market Share & Forecast

9.2.1.     By Product

9.2.2.     By Method

9.2.3.     By Plasma Source

9.2.4.     By Test

9.2.5.     By Donor

9.2.6.     By Application

9.2.7.     By End-User

9.2.8.     By Country

9.3.  Market Attractiveness Index

9.4.  South America: Country Analysis

9.4.1.     Brazil Plasma Fractionation Market Outlook

9.4.1.1.         Market Size & Forecast

9.4.1.1.1.             By Value

9.4.1.2.         Market Share & Forecast

9.4.1.2.1.             By Product

9.4.1.2.2.             By Method

9.4.1.2.3.             By Plasma Source

9.4.1.2.4.             By Test

9.4.1.2.5.             By Donor

9.4.1.2.6.             By Application

9.4.1.2.7.             By End-User

9.4.2.     Argentina Plasma Fractionation Market Outlook

9.4.2.1.         Market Size & Forecast